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Background:  Meta-analyses  conﬁrm  increased  circulating  C-reactive  protein  (CRP)  levels in  depression.
Longitudinal  studies  have  linked  one-off  measurements  of  CRP  at baseline  with  increased  risk  of  devel-
oping  depressive  symptoms  subsequently  at follow-up,  but studies  with  repeat  CRP  measures  from  the
same individuals  are scarce.
Methods:  We  have  examined  whether  longitudinal  patterns  of inﬂammation,  based  on  three  CRP  measure-
ments  from  childhood  to early-adulthood,  are  associated  with  the risk  of  depression  in  early-adulthood
in  the  Avon  Longitudinal  Study  of  Parents  and  Children,  a prospective  birth  cohort.
Results:  Using  Gaussian  mixture  modelling  of  available  CRP  data  from  age  9,  15  and  18  years,  we  identiﬁed
four  population  clusters/sub-groups  reﬂecting  different  longitudinal  patterns  of  CRP:  persistently  low
(N = 463,  29.5%);  persistently  high  (N =  371, 24%);  decreasing  (N  =  360,  23%);  increasing  (N =  367, 23.5%).
The  increasing  group  showed  a steep  increase  in  CRP  levels  between  adolescence  and  early-adulthood.
Participants  in this  group  had  a higher  risk of moderate/severe  depression  at age  18  years,  compared  with
those with  persistently  low  CRP;  adjusted  odds  ratio  (OR)  = 3.78  (95%  Conﬁdence  Interval  (CI),  1.46–9.81;
p  = 0.006).  The  odds  of moderate/severe  depression  were  also  increased  for the  persistently  high CRP
group,  but  this  was  not  statistically  signiﬁcant;  OR = 2.54  (95%  CI,  0.90–7.16).
Limitations:  Repeat  CRP  measures  were  available  for  a subset,  who  may  not  be  representative  of all cohort
participants.
Conclusions:  The  results  suggest  that  an  increasing  pattern  of inﬂammation  from  adolescence  to  early-
adulthood  is  associated  with  risk  of  depression  in  early-adulthood.
©  2019  The  Author(s).  Published  by Elsevier  Inc.  This  is an open  access  article  under  the  CC  BY  license. Introduction
Depression and other mood disorders are common in all pop-
lations [1], and a quarter of all cases emerge before 20 years of
ge [2,3]. Most current treatments for depression involve med-
cation that affects the brain monoamine systems [4], however
eterogeneity in clinical presentation and variability in treatment
esponse suggest additional mechanisms are present. There is now
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ever increasing evidence for an association between depression
and inﬂammation [5–12]. CRP has been used most extensively
as a measure of low-grade systemic inﬂammation in psychiatric
[11,13,14] and physical conditions [15,16]. Meta-analysis of cross-
sectional studies demonstrate that levels of CRP and inﬂammatory
cytokines, such as IL-6, are elevated in acute depression [7,17–19].
Similarly, longitudinal studies suggest that increased levels of
inﬂammatory markers in childhood/adolescence are associated
with increased risks of depression and psychosis subsequently
in adulthood [20–24]. Using prospective birth-cohort data, we
reported that higher levels of IL-6 in childhood are associated with
an increased risk of developing depression subsequently in early
adulthood in a dose-dependent manner [22]. We  also reported
that higher IL-6 levels in childhood are associated with subsequent
 under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ersistent depressive symptoms between the ages of 10 and 19
ears [25]. Other studies have also found a longitudinal association
etween circulating IL-6 and CRP levels and risk of depression at
ollow-up [20,26]. Findings from longitudinal studies of childhood
nﬂammatory markers suggest that inﬂammation precedes depres-
ion, so it could be a cause for depression rather than simply be a
onsequence of illness.
A feature of most existing epidemiological studies of depression
s that they used a one-off measure of CRP to gauge inﬂammation.
here is some evidence that CRP and IL-6 levels remain relatively
table over time [27,28], and studies have often excluded par-
icipants with suspected infection [22,29]. Nevertheless, repeated
easures within individuals over time allow to detect the level
nd longitudinal pattern of inﬂammation more accurately. To
ur knowledge, not many studies have examined the association
etween depression and longitudinal pattern of inﬂammation dur-
ng childhood, adolescence and young adulthood. We  are aware of
ne population-based longitudinal study that measured CRP ﬁve
imes between age 9 and 21 years [30]. Despite repeated measures,
RP data from only one assessment was used as predictor, reporting
o association with depression in adulthood.
We  have investigated the longitudinal pattern of inﬂammation
n the Avon Longitudinal Study of Parents and Children (ALSPAC),
 UK general population birth cohort. We  used data on serum CRP
evels assessed at ages 9, 15 and 18 years to create population sub-
roups reﬂecting longitudinal pattern of CRP using cluster analysis,
n unsupervised machine learning technique. We  hypothesised
hat persistently high or increasing levels of CRP from childhood
hrough to early-adulthood would be associated with the risk of
epression in early-adulthood assessed at age 18 years.
. Methods
.1. Cohort description and sample
The ALSPAC is a general population-based birth cohort. Preg-
ant women resident in former county Avon, UK, with expected
ates of delivery between 1st April 1991 and 31st December 1992
ere invited to take part in the study. The initial number of preg-
ancies enrolled is 14,541 (for these at least one questionnaire has
een returned or a “Children in Focus” clinic had been attended by
9/07/99). Of these initial pregnancies, there was a total of 14,676
oetuses, resulting in 14,062 live births and 13,988 children who
ere alive at 1 year of age.
Since age 7 years, the children attended annual clinical assess-
ents during which they participated in various face-to-face
nterviews and physical tests. When the oldest children were
pproximately 7 years of age, an attempt was made to bolster the
nitial sample with eligible cases who had failed to join the study
riginally. As a result, when considering variables collected from
he age of 7 onwards (and potentially abstracted from obstetric
otes) there are data available for more than the 14,541 pregnan-
ies mentioned above. The total sample size for analyses using any
ata collected after the age of 7 is therefore 15,247 pregnancies,
esulting in 15,458 foetuses. Of this total sample of 15,656 foetuses,
4,973 were live births and 14,899 were alive at 1 year of age.
Detailed information about the ALSPAC cohort can be found
n the study website (http://www.bristol.ac.uk/alspac), and the
ample characteristics and methodology have been described pre-
iously [31,32]. Please note that the study website contains details
f all the data that is available through a fully searchable data dic-
ionary and variable search tool (http://www.bristol.ac.uk/alspac/
esearchers/our-data/).
The risk set for the current study includes 1627 cohort mem-
ers who provided data on serum CRP levels at every follow-upehensive Psychiatry 96 (2020) 152143
at ages 9, 15 and 18 years. We  excluded 66 participants who  had
CRP levels >10 mg/l (marker of suspected infection) at any point. Of
the remaining risk set, 1462 participants took part in assessment
for depression at age 18 years and were therefore included in the
analyses.
Ethical approval for the study was obtained from ALSPAC Ethics
and Law Committee and the Local Research Ethics Committees.
Consent for biological samples has been collected in accordance
with the Human Tissue Act (2004).
2.2. Measurement of CRP
At age 9, non-fasting blood samples were taken using standard
procedures. At age 15, participants provided blood samples after a
fast of at least 6 hours. Samples were immediately spun and frozen
at −80 ◦C. There was no evidence of previous freeze–thaw cycles
during storage. For high sensitivity CRP (hsCRP) an automated
particle-enhanced immunoturbidimetric assay (Roche UK, Welwyn
Garden City, UK) was used. All assay coefﬁcients of variation were <
5%. At age 9, a valid measure of serum CRP was obtained from 5076
participants in total, which ranged from 0.01 to 67.44 mg/l (60 sub-
jects over 10 mg/l). At age 15, a valid measure of serum CRP was
obtained from 3490 participants in total, which ranged from 0.07
to 72.55 mg/l (60 subjects over 10 mg/l). Similar procedures were
followed for measuring CRP at age 18. A valid measure of serum CRP
was obtained from 3287 participants in total, which ranged from
0.02 to 176.1 mg/l (79 subjects over 10 mg/l).
2.3. Assessment of depression at 18 years
The computerised version of the Clinical Interview Schedule
Revised (CIS-R) was  self-administered by cohort participants in
assessment clinics at average age 17.8 years (SD = 0.38). The CIS-R
is a widely used, standardized tool for measuring common mental
disorders in large community samples [33]. In the UK, CIS-R has
been used in National Psychiatric Morbidity Survey, a household
survey on 10,000 individuals representative of the UK population,
in 1993 and 2007 [34,35]. The CIS-R is a fully structured assessment,
suitable for trained social survey interviewers and does not require
any expert knowledge on the part of the interviewers. As such, it
can also be administered using personal computers in which the
subjects self-complete the questionnaire [36].
The CIS-R elicits responses to symptoms of depression expe-
rienced in the past week, and provides a diagnosis of depression
according to ICD-10 criteria [37]. ICD-10 criteria for mild, moderate
and severe depression were used to categorise depression severity.
These were used as outcome.
2.4. Measurement of other variables
We  examined the association of CRP subgroups with sex,
maternal education, father’s occupation, weight at birth, mater-
nal Edinburgh Post-natal Depression Scale (EPDS) score, body
mass index (BMI) at age 18, total IQ score at age 8, atopic disor-
der in participants, and rheumatism or arthritis in either parent.
Sex was recorded at birth and was  coded as a binary variable.
Father’s occupation was  recorded at birth according to the UK Ofﬁce
of National Statistics Classiﬁcation System (Class I = professionals
and higher managerial workers; II = intermediate occupations;
IIIa = skilled non-manual occupations; IIIb = skilled manual occu-
pations; IV = partly skilled occupations; V = unskilled occupations),
and was  coded as a categorical variable (non-manual, i.e. I + II + IIIa,
v. manual occupations, i.e. IIIb + IV + V). Maternal depression was
measured by EPDS at 18-, 32-week gestation, and 8-week post-
partum. These three values were averaged and used as a continuous
variable. BMI  was  recoded at age 18 years, which was calculated
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s weight in kilograms divided by height in metre squared. Full
cale, verbal and performance IQ were measured by the Wechsler
ntelligence Scale for Children, 3rd UK edition (WISC III) (Wechsler
t al. 1992). A shortened version of the test was applied by trained
sychologists, whereby alternate items (always starting with item
umber 1 in the standard form) were used for all ten subtests with
he exception of the coding subtest, which was administered in
ts standard form. Assessment of atopy was done through a postal
uestionnaire completed by parents at age 10 years old. Parents
ere asked whether anytime in the past a doctor had stated that
he child suffered from asthma or eczema (original question: “Has
 doctor ever actually said that your study child has asthma or
czema?”). Based on response to this question a single categorical
xposure (or independent) variable was created, which included
our groups: no asthma or eczema (reference group); only asthma
r eczema; both asthma and eczema. Presence of a diagnosis of
heumatism or arthritis in either parent was also based on self-
eported questionnaire data.
.5. Statistical analysis
Statistical analyses and graph plotting were performed in R v3.4
38].
.5.1. CRP variables preparation and population clustering
Due to skewed distributions, CRP data were log-transformed,
nd all subsequent analyses performed on log(CRP). Longitudinal
opulation subgroups based on CRP data were created using Gaus-
ian ﬁnite mixture modelling. Gaussian ﬁnite mixture modelling
ses an expectation-maximisation algorithm; it is a ‘soft’ clustering
lgorithm which aims to ﬁnd a small number of classes, homoge-
eous with respect to patterns in observed data (in our case, CRP
evels over time). This is accomplished by decomposing complex
istributions in multivariate spaces into a small number of Gaus-
ian distributions. This procedure is implemented in R [38] within
he mclust package [39]. This package has been shown to outper-
orm similar packages [40]. Using this package, we  ﬁtted various
odels differing in the number of classes and cluster shapes. The
valuation of each model’s ﬁt and the determination of the optimal
umber of classes were based on the Bayesian Information Criterion
BIC).
.5.2. Descriptive analysis
Descriptive analyses were performed using the psych v1.7 [41]
ackage. The differences in prevalence between categorical vari-
bles were tested using 2 tests on contingency tables, while
ifferences in prevalence between continuous normally distributed
ariables were tested using ANOVA. Differences between several
ndependent groups of non-normal continuous values were tested
sing a Kruskal-Wallis 2 test.
.5.3. Calculation of odds ratios (OR) for depression
Multivariate multinomial log-linear models were used to cal-
ulate ORs and 95% conﬁdence intervals (CIs) for depression
ssociated with CRP subgroups. We  included sex, maternal educa-
ion, and BMI  at 18 years as potential confounders, because these
actors were associated with CRP sub-groups/clusters. Reference
ategories for the calculation of ORs were the persistently low
roup, male sex, lower maternal education (below A-level), and
bsence of depression. Analyses and plotting were performed using
he packages nnet v7.3 [42], ggplot2 v2.2 [43], Cairo v1.5 [44],
ridExtra v2.3 [45], dplyr v0.7 [46], and plyr v1.8 [47].hensive Psychiatry 96 (2020) 152143 3
3. Results
3.1. Population subgroups of inﬂammation based on CRP data at
ages 9, 15 and 18 years
Gaussian mixture modelling of the study population of 1561
participants with log(high-sensitivity CRP) values at 9, 15 and 18
years of age produced 2 potentially optimum models. Option 1 was
an ellipsoidal clustering, with variable orientation, equal volume
and shape, which identiﬁed 8 clusters in our data (BIC = -12631).
Option 2 was also an ellipsoidal clustering, this time with variable
orientation, volume and shape, which identiﬁed 4 clusters (BIC =
-12634). Following the principle of maximal parsimony, and given
that the BIC difference was minimal (3 points), we selected the
second model as optimum. The four population sub-groups of CRP
reﬂecting different patterns of inﬂammation over time were per-
sistently low (N = 463, 29.5%); decreasing (N = 360, 23%); increasing
(N = 367, 23.5%); and persistently high (N = 371, 24%). Subjects in
the persistently low group showed the lowest average CRP values
at all ages. Subjects in the decreasing group showed the second
highest CRP values at 9 and 15 years of age, which decreased to the
second lowest value at 18. Subjects in the increasing group showed
the second lowest CRP values at 9 and 15 years, which increased to
the highest levels at 18 years. Finally, subjects in the persistently
high group showed the highest CRP values at 9 and 15 years, and the
second highest at 18 (see Fig. 1, 3DFig. 1 : https://plot.ly/∼emosyne/
2.embed, and Supplementary Table 1). For distributions of CRP at
ages 9, 15 and 18 years, please see Supplementary results.
3.2. Association of CRP subgroups with sociodemographic and
other factors
Increasing and persistently high patterns of CRP were associ-
ated with female sex, higher BMI  at age 18, and lower maternal
educational attainment; see Table 1.
3.3. Association between CRP subgroups and depression at 18
years
The prevalence of depression for individuals in the four CRP
subgroups is presented in Table 1. Individuals in the increasing,
compared with low, CRP group had a higher risk of ICD-10 diagnosis
of depression at 18 years, but this was not statistically signiﬁcant;
adjusted OR 1.33 (95% CI, 0.73–2.39). Additional analysis based on
depression severity showed that belonging to the increasing CRP
group was  associated with moderate/severe depression at 18 years;
adjusted OR 3.78 (95% CI, 1.46–9.81); see Table 2. The odds of mod-
erate/severe depression were also increased for the persistently
high CRP group, compared with low CRP group, but this was  not
statistically signiﬁcant; adjusted OR 2.54 (95% CI, 0.90–7.16).
4. Discussion
Using population-based longitudinal birth-cohort data, we
identiﬁed population sub-groups of young people characterised
by different longitudinal patterns of peripheral inﬂammation lev-
els. Subjects who  showed a pattern of increasing CRP levels from
childhood to early adulthood had a higher risk of moderate/severe
depression at 18 years, compared with those who had persistently
low CRP. Evidence for this association remained after controlling
for sex, maternal education and BMI. Those with persistently ele-
vated CRP also had increased odds of moderate/severe depression
at 18, but this was not statistically signiﬁcant. The results indicate
that an increase in low-grade inﬂammation levels from childhood
to early adulthood is strongly associated with risk of depression in
early-adulthood.
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Fig. 1. Mean (SD) CRP Levels at Ages 9, 15 and 18 Years in Four Population Subgroups of CRP in the ALSPAC Cohort.
Table 1
Characteristics of Population Sub-groups of CRP in the ALSPAC Cohort.
Characteristic Total Sample Population subgroup of CRP Test statistic and p-value
Persistently low group Decreasing group Increasing group Persistently high group
Sample, n (%) 1561 (100%) 463 (30%) 360 (23%) 367 (24%) 371 (24%)
Male  sex, n (%) 770 (49%) 250 (54%) 184 (51%) 160 (44%) 176 (47%) 2 = 9.8, df = 3, p = 0.02
Maternal education (A level
and degree), n (%)
680 (46%) 181 (42%) 144 (42%) 173 (49%) 182 (51%) 2 = 9.8, df = 3, p = 0.02
Paternal social class
(non-manual occupations), n
(%)
422 (31%) 122 (31%) 81 (26%) 105 (31%) 114 (35%) 2 = 6.9, df = 3, p = 0.07
Birth weight, mean (SD), grams 3461.4 (530) 3503.2 (502) 3459.9 (546) 3407.9 (507) 3464.8 (565) F = 2.1, df = 3, p = 0.1
Maternal depression, average
EPDS score, median (IQR)
5.33 (5.67) 5.33 (5.67) 5.33 (5.67) 5.33 (5.00) 5.67 (5.33) Kruskal-Wallis 2 = 0.69,
df = 3, p = 0.88
BMI  at 18 years, mean (SD) 22.49 (3.59) 21.33 (2.57) 22.35 (3.37) 22.47 (3.51) 24.06 (4.32) F = 42.35, df = 3,
p < 0.0001
IQ  at 8 years, mean (SD) 109.21 (16.33) 109.39 (16.25) 110.09 (16.15) 108.62 (16.34) 108.73 (16.60) F = 0.597, df = 3, p = 0.62
Diagnosis of asthma or eczema,
n (%)
386 (26.9%) 110 (25.8%) 93 (28.0%) 99 (28.4%) 84 (25.5%) 2 = 5.8, df = 6, p = 0.44
Diagnosis of rheumatic disease
in parents, n (%)
53 (3.6%) 13 (3.0%) 15 (4.5%) 11 (3.1%) 14 (3.9%) 2 = 1.6, df = 3, p = 0.67
Arthritis in parents, n (%) 60 (4.0%) 14 (3.2%) 16 (4.7%) 19 (5.3%) 11 (3.1%) 2 = 3.5, df = 3, p = 0.31
Total  CIS-R score at 18, median
(IQR)
3 (7) 3 (7) 3 (6) 3 (7) 3 (6) Kruskal-Wallis 2 = 1.62,
df = 3, p = 0.65
CIS-R  total depression score at
18y, median (IQR)
2 (4) 1 (4) 2 (4) 1 (5) 2 (4) Kruskal-Wallis 2 = 1.24,
df = 3, p = 0.74
ICD-10 depression at 18y, n (%) 96 (6.6%) 29 (6.7%) 15 (4.5%) 28 (8.1%) 24 (6.9%) 2 = 3.7, df = 3, p = 0.30
ICD-10 depression at 18 by severity:
(95.5%
1%) 
4%) 
C
n
INo depression, n (%) 1366 (93.4%) 404 (93.3%) 318 
Mild  depression, n (%) 45 (3.1%) 19 (4.4%) 7 (2.
Moderate/severe, n (%) 51 (3.5%) 10 (2.3%) 8 (2.The increasing group showed a nearly 6-fold increase in average
RP levels between the ages of 15 and 18 years, and showed a sig-
iﬁcant association with moderate/severe depression at 18 years.
t is therefore possible that the strongest link between inﬂamma-) 318 (91.9%) 326 (93.1%)
2 = 11.1, df = 6, p = 0.089 (2.6%) 10 (2.9%)
19 (5.5%) 14 (4.0%)tion and depression lies in a recent increase, and that this is more
important than a chronically high CRP level with regards to future
risk of depression. Whether this recent CRP elevation could be a
mediating factor for links between depression and past psycho-
E.F. Osimo, J. Stochl, S. Zammit et al. / Comprehensive Psychiatry 96 (2020) 152143 5
Table  2
Association between Longitudinal Population Subgroups of CRP and Risk of Depression at Age 18 Years.
CRP Group Total Sample Any depression, No (%) Odds Ratio (95% CI) for Depression
Unadjusted Adjusted*
Persistently low N = 433 29 (6.7%) 1 [reference] 1 [reference]
Decreasing N = 333 15 (4.5%) 0.66 (0.35, 1.25) 0.80 (0.41, 1.59)
Increasing N = 346 28 (8.1%) 1.23 (0.72, 2.10) 1.33 (0.73, 2.39)
Persistently high N = 350 24 (6.9%) 1.03 (0.59, 1.80) 1.02 (0.54, 1.94)
CRP  Group Total Sample Moderate/Severe depression, No (%) Odds Ratio (95% CI) for Moderate/Severe depression
Unadjusted Adjusted*
Persistently low N = 433 10 (2.3%) 1 [reference] 1 [reference]
Decreasing N = 333 8 (2.4%) 1.02 (0.40, 2.60) 1.83 (0.62, 5.41)
Increasing N = 346 19 (5.5%) 2.41 (1.11, 5.26) 3.78 (1.46, 9.81)
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* Adjusted for sex, maternal education, BMI  at 18 years.
ogical stress, abuse/maltreatment is an important hypothesis that
eeds to be tested in further prospective samples.
Our ﬁndings add to increasing evidence supporting a link
etween the immune system, particularly low-grade systemic
nﬂammation deﬁned by elevated concentrations of circulating
nﬂammatory markers, and depression and other major men-
al disorders [6,48,49]. CRP is an acute phase protein which has
een studied extensively in depression and shown to be ele-
ated in acutely unwell patients compared with controls in several
eta-analyses [7,18,19]. Compounding cross-sectional evidence,
ecently longitudinal studies have shown that elevated cytokine
evels precede, and so could potentially cause, depressive symp-
oms: elevated IL-6 or CRP levels in childhood are associated
ith an increased risk of developing depression and psychosis
n adulthood [20,22,23,50]. We  are now more conﬁdent than
ver to suggest a causal role for inﬂammation in depression,
s two recent studies have used Mendelian randomisation to
urther investigate the matter. In [51], the authors ﬁnd that a
enotype variant associated with decreased CRP levels is also asso-
iated with reduced odds of depression. In [52], the authors found
hat a poly-genic risk score for high CRP levels was signiﬁcantly
ssociated with increases in the risk of depression. These stud-
es suggest that, if the genes linked with high CRP are linked
ith an increase in the risk of depression, it is unlikely that this
ssociation is only due to a true causal link rather than reverse
ausation or confounding. This study adds to the existing evi-
ence by showing that increasing CRP levels between adolescence
nd young-adulthood are associated with a subsequent ICD-10
iagnosis of moderate/severe depression in young-adulthood at
ge 18 years. This ﬁnding ﬁts nicely with a causal role of high
RP in depression, as it means that depression is most likely to
anifest when CRP levels rise close to the index time of examina-
ion.
Based on repeat measure of CRP we report that individuals
ith increasing levels of inﬂammation over time, especially dur-
ng adolescence, have higher risk of moderate/severe depression
n early-adulthood. In this study we did not examine potential
easons for the increases in CRP levels during adolescence, but
his is likely to include both genetic and environmental factors.
dolescence is a time of profound physical and psychological trans-
ormation. This is also a stressful time for many individuals due to,
or instance, forming new relationships, peer pressure, bullying.
ncreasing independence and experimentation during this devel-
pmental epoch is also associated with fast-food consumption,
moking, drinking, substance use - all of these factors could increase
evels of inﬂammation. In future, studies are required to test why  a
ub-group of adolescents experience a sharp increase in their level
f inﬂammation.1.73 (0.76, 3.96) 2.54 (0.90, 7.16)
4.1. Strengths
The use of a general population birth cohort, a relatively large
sample, and particularly repeated prospective assessment of an
inﬂammatory marker are some of the strengths of this study. The
exclusion of participants with CRP levels of >10 mg/l at any point
minimised potential confounding by chronic inﬂammatory con-
ditions or current infection. In addition, we adjusted regression
models for maternal education (a marker of socio-economic status),
sex and BMI, which are linked with inﬂammation levels.
4.2. Limitations
A key limitation is missing data. Of 14,062 live births in ALSPAC,
1627 cohort members provided serum CRP levels at all time points
of 9, 15 and 18 years of age. Out of these, we excluded 66 partici-
pants who, at any point, had CRP levels >10 mg/l, and of these, 1462
participants took part in psychiatric assessment at age 18 years and
were therefore included in this study. Thus, the group with CRP
data at all three time points that formed the basis for our analy-
sis may  not be representative of all ALSPAC participants. Attrition
in prospective cohort studies including ALSPAC is associated with
lower socio-economic status and increased mental illness. Selective
attrition of participants more likely to have the outcome of interest
(depression) may  have increased the possibility of null ﬁndings in
our sample. Due to a limited sample size for repeat CRP data, we
did not include additional confounders such as childhood trauma,
smoking, poor diet, low levels of physical activity, and sleep distur-
bance, as this would have reduced the sample size further, leading
to decreased statistical power.
4.3. Conclusions
In summary, using repeated measurements of CRP from child-
hood to young-adulthood, we report that an increasing pattern
of inﬂammation from adolescence to early-adulthood is associ-
ated with risk of moderate/severe depression in early-adulthood.
Future studies should investigate the causes of this increase in
inﬂammatory markers in the second decade of life in previously
non-inﬂamed individuals, and the relationship these causes may
have with depression.
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